129 related articles for article (PubMed ID: 12895692)
1. Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate.
Bocklandt S; Blumberg PM; Hamer DH
Antiviral Res; 2003 Jul; 59(2):89-98. PubMed ID: 12895692
[TBL] [Abstract][Full Text] [Related]
2. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.
De la Torre-Tarazona HE; Jiménez R; Bueno P; Camarero S; Román L; Fernández-García JL; Beltrán M; Nothias LF; Cachet X; Paolini J; Litaudon M; Alcami J; Bedoya LM
Biochem Pharmacol; 2020 Jul; 177():113937. PubMed ID: 32224142
[TBL] [Abstract][Full Text] [Related]
3. Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.
Kulkosky J; Culnan DM; Roman J; Dornadula G; Schnell M; Boyd MR; Pomerantz RJ
Blood; 2001 Nov; 98(10):3006-15. PubMed ID: 11698284
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation.
Márquez N; Calzado MA; Sánchez-Duffhues G; Pérez M; Minassi A; Pagani A; Appendino G; Diaz L; Muñoz-Fernández MA; Muñoz E
Biochem Pharmacol; 2008 Mar; 75(6):1370-80. PubMed ID: 18241838
[TBL] [Abstract][Full Text] [Related]
5. Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV).
Gulakowski RJ; McMahon JB; Buckheit RW; Gustafson KR; Boyd MR
Antiviral Res; 1997 Jan; 33(2):87-97. PubMed ID: 9021050
[TBL] [Abstract][Full Text] [Related]
6. Novel phorbol esters exert dichotomous effects on inhibition of HIV-1 infection and activation of latent HIV-1 expression.
Zhong Y; Matsuya Y; Nemoto H; Mori M; Saito H; Yamamoto N
Antivir Chem Chemother; 2005; 16(5):303-13. PubMed ID: 16245646
[TBL] [Abstract][Full Text] [Related]
7. Prostratin: An Overview.
Miana GA; Riaz M; Shahzad-ul-Hussan S; Paracha RZ; Paracha UZ
Mini Rev Med Chem; 2015; 15(13):1122-30. PubMed ID: 25963564
[TBL] [Abstract][Full Text] [Related]
8. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
[TBL] [Abstract][Full Text] [Related]
9. Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo.
Beans EJ; Fournogerakis D; Gauntlett C; Heumann LV; Kramer R; Marsden MD; Murray D; Chun TW; Zack JA; Wender PA
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11698-703. PubMed ID: 23812750
[TBL] [Abstract][Full Text] [Related]
10. Effects of prostratin on T-cell activation and human immunodeficiency virus latency.
Korin YD; Brooks DG; Brown S; Korotzer A; Zack JA
J Virol; 2002 Aug; 76(16):8118-23. PubMed ID: 12134017
[TBL] [Abstract][Full Text] [Related]
11. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
Rochat MA; Schlaepfer E; Speck RF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
[TBL] [Abstract][Full Text] [Related]
12. A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1.
Gustafson KR; Cardellina JH; McMahon JB; Gulakowski RJ; Ishitoya J; Szallasi Z; Lewin NE; Blumberg PM; Weislow OS; Beutler JA
J Med Chem; 1992 May; 35(11):1978-86. PubMed ID: 1597853
[TBL] [Abstract][Full Text] [Related]
13. Prostratin as a new therapeutic agent targeting HIV viral reservoirs.
Hezareh M
Drug News Perspect; 2005 Oct; 18(8):496-500. PubMed ID: 16391719
[TBL] [Abstract][Full Text] [Related]
14. New phorbol ester derivatives as potent anti-HIV agents.
Li QR; Cheng YY; Zhao L; Huang XL; Jiang XG; Cui YD; Morris-Natschke SL; Goto M; Chen CH; Lee KH; Chen DF; Zhang J
Bioorg Med Chem Lett; 2021 Oct; 50():128319. PubMed ID: 34403728
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of HIV receptor and co-receptor down-regulation by prostratin: role of conventional and novel PKC isoforms.
Hezareh M; Moukil MA; Szanto I; Pondarzewski M; Mouche S; Cherix N; Brown SJ; Carpentier JL; Foti M
Antivir Chem Chemother; 2004 Jul; 15(4):207-22. PubMed ID: 15457682
[TBL] [Abstract][Full Text] [Related]
16. HIV type 1 inhibition by protein kinase C modulatory compounds.
Warrilow D; Gardner J; Darnell GA; Suhrbier A; Harrich D
AIDS Res Hum Retroviruses; 2006 Sep; 22(9):854-64. PubMed ID: 16989610
[TBL] [Abstract][Full Text] [Related]
17. Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR.
Abreu CM; Price SL; Shirk EN; Cunha RD; Pianowski LF; Clements JE; Tanuri A; Gama L
PLoS One; 2014; 9(5):e97257. PubMed ID: 24827152
[TBL] [Abstract][Full Text] [Related]
18. Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV.
Wender PA; Kee JM; Warrington JM
Science; 2008 May; 320(5876):649-52. PubMed ID: 18451298
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV Activities and Mechanism of 12-O-Tricosanoylphorbol-20-acetate, a Novel Phorbol Ester from Ostodes katharinae.
Chen H; Zhang R; Luo RH; Yang LM; Wang RR; Hao XJ; Zheng YT
Molecules; 2017 Sep; 22(9):. PubMed ID: 28885587
[TBL] [Abstract][Full Text] [Related]
20. Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents.
Kulkosky J; Sullivan J; Xu Y; Souder E; Hamer DH; Pomerantz RJ
AIDS Res Hum Retroviruses; 2004 May; 20(5):497-505. PubMed ID: 15186524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
